Rexulti 3 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMH6W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,062
Award facts
- Contract value 100% obligated
- $22,061.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $22,061.64, was awarded to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of REXULTI 3 mg tablets (30-count units) to support federal medical procurement needs. The contract is a firm fixed price delivery order with a completion deadline of December 8, 2025, and the place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This award carries no set-aside designation, indicating it was competitively awarded through open federal procurement channels. The Defense Logistics Agency, a defense-focused federal procurement entity, is the funding agency for this pharmaceutical supply contract.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and federal medical supply chains. The DLA Troop Support Medical IDC enables AmerisourceBergen to serve critical customers including the Defense Health Agency and other government healthcare systems with flexible pharmaceutical support capabilities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FMH6W?
SPE2DR26FMH6W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FMH6W worth?
The government has obligated $22,062 on SPE2DR26FMH6W.
Is contract SPE2DR26FMH6W an order under another contract?
Yes. SPE2DR26FMH6W is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH6W competed?
The extent of competition for SPE2DR26FMH6W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award